Surprisingly, however, analysis of JAM-A immunohistochemical staining in a 174-case GE tumor TMA did not reveal any significant correlations between JAM-A protein expression and clinicopathological features such as tumor grade, proliferation, Lauren classification, differentiation, TNM-staging or HER2-positivity. Here, ERBB2 is linked to neoplasm.